Remicade^【○!R】 (infliximab) : Two Year Results from the ATTRACT Study Demonstrate Sustained Benefits in Signs and Symptoms, Structural Damage and Physical Function in Patients with Rheumatoid Arthritis
スポンサーリンク
概要
- 論文の詳細を見る
- 2001-04-17
著者
-
Maini R.
London United Kingdom
-
HARRIMAN G.
London, United Kingdom
-
VAN DER
London, United Kingdom
-
CLAIR E.
London, United Kingdom
-
FURST D.
London, United Kingdom
-
BREEDVELD F.
London, United Kingdom
-
KALDEN J.
London, United Kingdom
-
SMOLEN J.
London, United Kingdom
-
WEISMAN M.
London, United Kingdom
-
EMERY P.
London, United Kingdom
-
FELDMAN M.
London, United Kingdom
-
LIPSKY P.
London, United Kingdom
-
Furst D.
London United Kingdom
-
Lipsky P.
London United Kingdom
-
Smolen J.
London United Kingdom
-
Kalden J.
London United Kingdom
-
Weisman M.
London United Kingdom
-
Harriman G.
London United Kingdom
-
Breedveld F.
London United Kingdom
-
Emery P.
London United Kingdom
-
Feldman M.
London United Kingdom
-
Clair E.
London United Kingdom
-
Van Der
London United Kingdom